These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Incidence of occult malignancies identified during hysterectomies performed for benign indications. Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888 [TBL] [Abstract][Full Text] [Related]
10. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy. Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176 [TBL] [Abstract][Full Text] [Related]
11. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review. Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395 [TBL] [Abstract][Full Text] [Related]
14. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids. Cui RR; Wright JD Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385 [TBL] [Abstract][Full Text] [Related]
15. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation. Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835 [TBL] [Abstract][Full Text] [Related]
16. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications. Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228 [TBL] [Abstract][Full Text] [Related]
17. Uterine morcellation and survival in uterine sarcomas. Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231 [TBL] [Abstract][Full Text] [Related]
18. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications. Ding Y; Han Y; Zhang S; Shi X J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311 [TBL] [Abstract][Full Text] [Related]
19. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat? Mettler L; Abdusattarova K; Alkatout I Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease. Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]